çŸåšããŠã€ã«ã¹ã®æ§é ãææåããŠã€ã«ã¹ãšæŠãæ¹æ³ã«ã€ããŠå€ãã®è°è«ãè¡ãããŠããŸãããããŠããã¯æ£ããã®ã§ããããããåæ§ã«éèŠãªããŒãã§ããã³ãããŠã€ã«ã¹ã®ãã³ãããã¯ã®åå ã«ã¯ãã©ããããããã»ãšãã©æ³šç®ãæãããŠããŸããããããŠã以åã®ã³ãããŠã€ã«ã¹ã®æµè¡åŸã®å Žåã®ããã«ãåå ãç解ãããé©åãªçµè«ãå°ãåºããªããã°ã次ã®å€§èŠæš¡ãªæµè¡ãããã»ã©é ããªããã¡ã«èµ·ããã§ãããã
人ã ã®ãäºããç°å¢ã«å¯ŸããçŸåšã®ç¡è²¬ä»»ã§æ¶è²»è 䞻矩çãªæ 床ã¯ããã§ã«äœ¿ãæããããŠãããšããããšãæçµçã«ç解ããå¿ èŠããããŸãããããŠèª°ãå®å¿ããããšã¯ã§ããŸãããä»ã®äžçã§ã¯ãä»äººãçããèªç¶ããé¢ããŠããèªåèªèº«ãã®å¹žçŠãåµé ããããšã¯äžå¯èœã§ãã 821 å XNUMX äžäººãå®æçã«é£¢ãã«é¥ãïŒææ°ã®åœé£ããŒã¿ã«ãããšïŒãæ è¡ãç±åž¯ã®çŸããã楜ãã¿ãçç£ããé£æã® XNUMX åã® XNUMX ãæšãŠãŠãã人ãããã®ã«ããã®äºæ ãããŸãçµããããããšã¯ã§ããŸããã人é¡ã¯ãäžã€ã®äžçãäžã€ã®å¥åº·ãã¢ãã«ã§ã®ã¿æ£åžžã«ååšã§ããŸããããã«ã¯æ¶è²»è ã®æ 床ã¯ãªããå°ççæ ç³»å šäœã®çžäºå©çã®ååšã«å¯Ÿããåççãªã¢ãããŒãããããŸãã
ãã¥ãŒãšãŒã¯ã»ã¿ã€ã ãºçŽã®ããããã»ã¯ã¢ã³ãã³ã®èšäºã¯ããã«ã€ããŠã§ãã
ã³ãããŠã€ã«ã¹ã®è延ãåŒãèµ·ãããã®ã¯æã ã
ããã¯æŽçªã®ã³ãŠã¢ãªããå§ãŸã£ããããããŸããããããã»ã¹ãéå§ããã®ã¯äººéã®æŽ»åã§ããã
ãŠã€ã«ã¹ãåé¢ã»åå®ããäžåœã®ç§åŠè ããŒã ãéžãã ååã¯ã2019幎ã®æ°åã³ãããŠã€ã«ã¹ãnCoV-2019ãã®ç¥ç§°ã ã (ãã®èšäºã¯ããŠã€ã«ã¹ã«çŸåšã®åå SARS-Cov-2 ãäžããããåã«æ²èŒãããŸããã - A.R.).
æ°ãããŠã€ã«ã¹ã®ååã«ãããããããåœåè
ã¯ããç¥ã£ãŠããããã«ãnCoV-2019 ã¯ããªããæã£ãŠããã»ã©æ°ãããã®ã§ã¯ãããŸããã
åæ§ã®ãã®ã¯æ°å¹ŽåãæŠæŒ¢ã®å西çŽåãã€ã«ã«ããé²åçã®æŽçªã§ãæŽå¯åã®ããç 究è
ã®ã°ã«ãŒãã«ãã£ãŠçºèŠãããŠããã圌ãã®çºèŠã«æžå¿µãæã£ãŠæ³šç®ããŠããã nCo2V-019 ã®æ¥éãªè延ã¯é©ãã¹ããã®ã§ãããäºæž¬ã§ããªãããã§ã¯ãããŸããããŠã€ã«ã¹ã人éã§ã¯ãªãåç©ãããããã³ãŠã¢ãªããçºçããããããå¥ã®çç©ãééããåŸã«çºçãããšããããšã¯ãé©ãã¹ãããšã®ããã«æãããããããªãããããããã®ãããªããšãç 究ããŠããç§åŠè
ã«ãšã£ãŠãããã¯é©ãã¹ãããšã§ã¯ãããŸããã
ãã®ãããªç§åŠè ã®äžäººã¯ãnCoV-2019 ã®ååã®ç±æ¥ãšãªã£ãæŠæŒ¢ãŠã€ã«ã¹ç 究æã® Zheng-Li Shi å士ã§ãã 2005 幎ã«ãSARS ã®åå ç©è³ªã¯äººã ã«åºããã³ãŠã¢ãª ãŠã€ã«ã¹ã§ããããšã蚌æããã®ã¯ãZheng-Li Shi ãšåœŒã®ååã§ããããã以æ¥ãç 究ããŒã ã¯ã³ãŠã¢ãªã®ã³ãããŠã€ã«ã¹ã远跡ããŠãããäžã«ã¯äººéã«ãã³ãããã¯ãåŒãèµ·ããã®ã«ç¹ç°ãªæ§è³ªãæã€ãã®ããããšèŠåããŠããã
2017幎ã®è«æã®äžã§ã圌ãã¯é²åçã®æŽçªã§ã³ãŠã¢ãªããç³äŸ¿ãµã³ãã«ã96幎è¿ãåéããåŸããã¯ã¬ã·ã©ã³ãŠã¢ãªãå«ã2019çš®ã®ç°ãªãã³ãŠã¢ãªã®æ°åäœããã³ãããŠã€ã«ã¹ãçºèŠããæ¹æ³ã説æãããç§åŠè ãã¯ããã®ãŠã€ã«ã¹ã®ã²ãã ã¯æè¿äººéã§çºèŠãããæŠæŒ¢ãŠã€ã«ã¹ãšXNUMXããŒã»ã³ãåäžã§ãããšè¿°ã¹ãŠããããããŠããã® XNUMX ã€ã¯ãSARS ãåŒãèµ·ããã³ãããŠã€ã«ã¹ãå«ãä»ã®ãã¹ãŠã®æ¢ç¥ã®ã³ãããŠã€ã«ã¹ãšã¯ç°ãªããã¢ã圢æããŸãããã®æå³ã§ãnCoV-XNUMX ã¯æ°ãããããããä»ã®ã³ãããŠã€ã«ã¹ããã人éã«ãšã£ãŠããã«å±éºã§ãã
ãã¥ãŒãšãŒã¯åžã«æ¬æ ã眮ãã人éã®å¥åº·ãšéçåç©ãšã®é¢é£ã«çŠç¹ãåœãŠãŠããæ°éç 究çµç¹ã§ãããšã³ãã«ã¹ã»ã¢ã©ã€ã¢ã³ã¹ã®äŒé·ã§ããããŒã¿ãŒã»ãã¶ãã¯æ°ã¯ãééºç³å士ã®é·å¹Žã®ããŒãããŒã®äžäººã§ãã ãç§ãã¡ã¯15幎éããããã®ãŠã€ã«ã¹ã«ã€ããŠèŠéã鳎ããç¶ããŠããŸããããšåœŒã¯éãã«å€±æããªããèªã£ãã ãSARSãå§ãŸã£ãŠãããã圌ã¯ã³ãŠã¢ãªãšSARSã«é¢ãã2005幎ã®ç 究ãšãé²åçã®æŽçªã§çºçããè€æ°ã®SARSã«äŒŒãã³ãããŠã€ã«ã¹ã«é¢ãã2017幎ã®è«æã®å ±èè ã§ããã
ãã¶ã¯æ°ã¯ããã®400åç®ã®èª¿æ»äžã«ãçŸå°ããŒã ã¯3人ã®é²å人ããè¡æ¶²ãµã³ãã«ãæ¡åãããã®ãã¡çŽXNUMX人ã¯æŽçªã®è¿ãã«äœãã§ãããšè¿°ã¹ãããã®ãã¡çŽXNUMXïŒ ã¯SARSã«äŒŒãã³ãããŠã€ã«ã¹ã«å¯Ÿããæäœãæã£ãŠããã
ã圌ããç æ°ã«ãªã£ããã©ããã¯ããããŸããããããããã®ããšããåããããšã¯ããããã®ãŠã€ã«ã¹ã¯ã³ãŠã¢ãªãã人éã«äœåºŠãé£ã³ç§»ããšããããšã§ãããèšãæããã°ãä»åã®æŠæŒ¢ã®ç·æ¥äºæ ã¯æ°ããåºæ¥äºã§ã¯ãªããããã¯éå»ã«é¡ããçŸåšã®ç¶æ³ãç¶ãéãå°æ¥ãç¶ãäžé£ã®é¢é£äžæž¬ã®äºæ ã®äžéšã§ãã
ãããã£ãŠãä»åã®æµè¡ã«ã€ããŠå¿é ãçµãã£ããã次ã®æµè¡ã«ã€ããŠå¿é ããŠãã ããããããã¯çŸç¶ãäœãšãããã
çŸåšã®ç¶æ³ã«ã¯ãå±éºãªéçåç©ãé£åã®ååŒãå«ãŸããŠããããµãã©ã€ãã§ãŒã³ã¯ã¢ãžã¢ãã¢ããªã«ããããŠçšåºŠã¯äœããã®ã®ç±³åœããã®ä»ã®åœã ã«åºãã£ãŠããŸãããã®ååŒã¯äžåœã§äžæçã«çŠæ¢ããããããããããã¯SARSã®ãšããèµ·ããããã®åŸãæŠæŒ¢ãªã©ã®åžå Žã«ã³ãŠã¢ãªããžã£ã³ãŠãã³ãã€ãã¢ã©ã·ãã«ã¡ãã¿ã±ããºããå€ãã®çš®é¡ã®é³¥ããã®ä»ã®åç©ãäžç·ã«ç©ã¿äžããããŠãåã³ååŒãèš±å¯ãããã
çŸåšã®ç¶æ³ã«ã¯ãåžžã«é£æãå¿ èŠãšããŠããå°çäžã® 7,6 å人ãå«ãŸããŸãã貧ããã¿ã³ãã¯è³ªãäžè¶³ããŠãã人ãããŸããè£çŠã§æµªè²»å®¶ã§ãé£è¡æ©ã§å°çäžã®ããŸããŸãªå Žæã«æ è¡ããäœè£ã®ãã人ãããŸãããããã®èŠå ã¯å°çäžã§ã¯åäŸã®ãªããã®ã§ããç§ãã¡ã¯åç³ã®èšé²ãããä»æ¥ã®äººé¡ã»ã©å€ãã®å€§ååç©ãååšããªãã£ãããšãç¥ã£ãŠããŸãããããŠããã®è±ããããã®åããããŠããã«äŒŽãçæ ç³»ã®ç Žå£ã®çµæã®XNUMXã€ã¯ããŠã€ã«ã¹äº€æã®å¢å ã§ããæåã¯åç©ãã人éãžã次ã«äººéãã人éãžãæã«ã¯ãã³ãããã¯ã®ãããªèŠæš¡ã«ãŸã§åºãããŸãã
ç§ãã¡ã¯ãéåžžã«å€ãã®çš®ã®åæ€ç©ãšãã®äžã«éåžžã«å€ãã®æªç¥ã®ãŠã€ã«ã¹ãçæ¯ããç±åž¯æããã®ä»ã®éçã®é¢šæ¯ã«äŸµå ¥ããŠããŸããç§ãã¡ã¯æšãåãåããŸããç§ãã¡ã¯åç©ã殺ãã檻ã«å ¥ããŠåžå Žã«éããŸããç§ãã¡ã¯çæ ç³»ãç Žå£ãããŠã€ã«ã¹ãèªç¶å®¿äž»ããé ãããŸãããããªã£ãå Žåãæ°ããææè ãå¿ èŠã«ãªããŸããå€ãã®å Žåãããã¯ç§ãã¡ã§ãã
人éã®äœå ã«åºçŸãããã®ãããªãŠã€ã«ã¹ã®ãªã¹ãã¯ããŸãã§æããã倪éŒã®é³ã®ããã«èãããïŒããã¥ããããªãã¢ã1961幎ããã€ããããŒã«ãã«ã¯ã1967幎ããšãã©åºè¡ç±ãã¶ã€ãŒã«ãã¹ãŒãã³ã1976幎ã HIVããã¥ãŒãšãŒã¯ãšã«ãªãã©ã«ãã¢ã1981幎ããã³ãã®ãã©ãŒã ïŒçŸåšã¯ã·ã³ã»ãã³ãã¬ãšããŠç¥ãããŠããïŒãç±³åœå西éšã1993幎ããã³ãã©ããªãŒã¹ãã©ãªã¢ã1994幎ãé³¥ã€ã³ãã«ãšã³ã¶ éŠæž¯ 1997幎ããã¬ãŒã·ã¢ãããã1998幎ã西ãã€ã«å·ããã¥ãŒãšãŒã¯å·ã1999幎ã SARSãäžåœã2002 ïœ 3 幎ã MERSããµãŠãžã¢ã©ãã¢ã2012幎ããšãã©åºè¡ç±åã³ã西ã¢ããªã«ã2014幎ããããŠããã¯éžæçãªãã®ã«ãããŸãããä»ãç§ãã¡ã¯nCoV-2019ã«æåŸã®ææãäžããŠããŸãã
çŸåšã®ç¶æ³ã«ã¯ãæªããã¥ãŒã¹ãåãã€ãããé ãããããå®åããææ¥ã蟲æ¥ã§ã®éçšãåµåºããããã«æ£®æãäŒæ¡ããããå»çãç 究ã®äºç®ãåæžãããããŠãããšçŸ€è¡ã«èªæ ¢ããéžæã§éžã°ãã圹人ãå«ãŸããŠãããæŠæŒ¢ãã¢ããŸã³ããããªãããã³ããã¯ã·ã³ãã³ãŸã§ã®è·é¢ã¯ãäžéšã®ãŠã€ã«ã¹ã«ãšã£ãŠã¯ãé£è¡æ©ã®ä¹å®¢ãšäžç·ã«ããŸã移åã§ããããšãèãããšãæ°æéã§æž¬ããšçãããŸãããã³ãããã¯ãžã®åãã«è³éãæå ¥ããã®ã¯é«äŸ¡ã ãšæããªããçŸåšã®ãã³ãããã¯ã®æçµçãªã³ã¹ããããããŸã§åŸ ã£ãŠãã ããã
幞ããªããšã«ãçŸåšã®ç¶æ³ã«ã¯ãæŠæŒ¢ãŠã€ã«ã¹ç 究æããšã³ãã«ã¹ã»ã¢ã©ã€ã¢ã³ã¹ãç±³åœçŸç äºé²ç®¡çã»ã³ã¿ãŒïŒCDCïŒãäžåœCDCããã®ä»å€ãã®æ©é¢ã®ç§åŠè ãªã©ãåªç§ã§ç®èº«çãªç§åŠè ãã¢ãŠããã¬ã€ã¯å¯Ÿå¿ã®å°é家ãå«ãŸããŠããŸãã圌ãã¯ãã²ãã é åãç 究ããéèŠãªçåã«çããããã®ç³äŸ¿ãè¡æ¶²ããã®ä»ã®è²ŽéãªèšŒæ ãå ¥æããããã«ãã³ãŠã¢ãªã®æŽçªã沌å°ãå³éãªã»ãã¥ãªãã£ã®ç 究æã«å ¥ãããã°ãã°åœãå±éºã«ããããŸãã
æ°åã³ãããŠã€ã«ã¹ã®ææè æ°ãšããã«äŒŽãæ»è æ°ãå¢å ããäžãææšã®3ã€ã§ããèŽæ»çã¯ãããŸã§ã®ãšããããªãå®å®ããŠãããXNUMXïŒ ä»¥äžãšãªã£ãŠãããããã¯çžå¯Ÿçãªæåã§ãããã»ãšãã©ã®ã€ã³ãã«ãšã³ã¶æ ªãããæªããSARS ããã¯åªããŠããŸãã
ãã®å¹žéã¯é·ãã¯ç¶ããªããéçºãã©ããªããã¯èª°ã«ãããããŸãããå幎åŸã«ã¯æŠæŒ¢èºçã¯æŽå²ã«ãªããããããªãããåŠãã
ç§ãã¡ã¯çæãšé·æãšãã 2019 ã€ã®å€§ããªèª²é¡ã«çŽé¢ããŠããŸããçæç: ç§ãã¡ã¯ãã§ããéãå£æ» çãªäžççãã³ãããã¯ã«ãªãåã«ããã® nCoV-2019 ã®æµè¡ãå°ã蟌ããæ¶æ» ãããããã«ãç¥æµãçµããå·éãã€è³æºãæ倧éã«æå ¥ããå šåãå°œãããªããã°ãªããŸãããé·æç: äºæ ãåæãããšããnCoV-XNUMX ã¯æ°ããåºæ¥äºãç§ãã¡ã«éãããã£ãçœå®³ã§ã¯ãªãã£ããšããããšãèŠããŠããå¿ èŠããããŸããããã¯ç§ãã¡äººéãèªåèªèº«ã®ããã«è¡ãéžæã®ãã¿ãŒã³ã®äžéšã§ããã
翻蚳: A. ã«ãžã§ã·ã§ãã¹ããŒã
åºæïŒ habr.com